The origin of interstitial myofibroblasts in chronic kidney disease

Ivica Grgic, Jeremy S. Duffield, Benjamin D. Humphreys

Research output: Contribution to journalReview articlepeer-review

135 Scopus citations

Abstract

Chronic kidney diseases (CKD), independent of their primary cause, lead to progressive, irreversible loss of functional renal parenchyma. Renal pathology in CKD is characterized by tubulointerstitial fibrosis with excessive matrix deposition produced by myofibroblasts. Because blocking the formation of these scar-forming cells represents a logical therapeutic target for patients with progressive fibrotic kidney disease, the origin of renal myofibroblasts is a subject of intense investigation. Although the traditional view holds that resident fibroblasts are the myofibroblast precursor, for the last 10 years, injured epithelial cells have been thought to directly contribute to the myofibroblast pool by the process of epithelial-to-mesenchymal transition (EMT). The recent application of genetic fate mapping techniques in mouse fibrosis models has provided new insights into the cell hierarchies in fibrotic kidney disease and results cast doubt on the concept that EMT is a source of myofibroblast recruitment in vivo, but rather point to the resident pericyte/perivascular fibroblast as the myofibroblast progenitor pool. This review will highlight recent findings arguing against EMT as a direct contributor to the kidney myofibroblast population and review the use of genetic fate mapping to elucidate the cellular mechanisms of kidney homeostasis and disease.

Original languageEnglish
Pages (from-to)183-193
Number of pages11
JournalPediatric Nephrology
Volume27
Issue number2
DOIs
StatePublished - Feb 2012

Keywords

  • Chronic kidney disease
  • EMT
  • Fibrosis
  • Genetic fate mapping
  • Myofibroblast

Fingerprint Dive into the research topics of 'The origin of interstitial myofibroblasts in chronic kidney disease'. Together they form a unique fingerprint.

Cite this